-
THE ECONOMIC IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS IN RESECTABLE GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS IN A CANADIAN SETTING
Mar 18, 2026, 21:38 PM -
CLINICAL OUTCOMES AND ECONOMIC BURDEN FOLLOWING TREATMENT FOR UNRESECTABLE OR METASTATIC ESOPHAGEAL CANCER
Mar 18, 2026, 21:38 PM -
TRENDS AND ANNUALIZED CHANGES IN HUMAN PAPILLOMAVIRUS (HPV) VACCINATION AMONG ADOLESCENTS IN THE UNITED STATES, 2013-2023
Mar 18, 2026, 21:38 PM -
CHARACTERISTICS, TREATMENT PATTERNS, AND OUTCOMES OF PATIENTS WITH NON-SMALL CELL LUNG CANCER ACROSS CLINICO-GENOMIC DATABASE AND ELECTRONIC MEDICAL RECORDS
Mar 18, 2026, 21:38 PM -
GLOBAL PREVALENCE AND CLINICAL PRESENTATION OF ALOPECIA AREATA: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF A LOW-THRESHOLD MOBILE MEDICAL UNIT PROVIDING OPIOID USE DISORDER CARE IN AN URBAN SETTING
Mar 18, 2026, 21:38 PM -
COMPARING TEST-RETEST RELIABILITY AND RESPONSIVENESS OF EQ-5D-5L WITH FOUR BOLT-ONS, PROMIS-29 AND SKINDEX-16 IN PSORIASIS AND ATOPIC DERMATITIS PATIENTS
Mar 18, 2026, 21:38 PM -
EVALUATING THE PATIENT BURDEN ASSOCIATED WITH DELAYED REIMBURSEMENT: A CASE STUDY OF PEMBROLIZUMAB IN THE TREATMENT OF ENDOMETRIAL CANCER IN CANADA
Mar 18, 2026, 21:38 PM -
PREVALENCE OF IMMUNOCOMPROMISED CONDITIONS AMONG PATIENTS WITH ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
PREVALENCE, RISK FACTORS, AND SAFETY IMPLICATIONS OF POTENTIALLY INAPPROPRIATE MEDICATION USE AMONG OLDER ADULTS WITH DEMENTIA: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
DRUG SHORTAGES FINAL RULE RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
ONE BIG BEAUTIFUL ACT (OBBA) MEDICAID FUNDING CHANGES IMPACT ON MEDICAID VOLUMES IN CLAIMS DATA; A STUDY OF IMPACT FROM REENROLLMENT REQUIREMENTS OF 2024
Mar 18, 2026, 21:38 PM -
EXPANDING ACCESS TO LONG-ACTING REVERSIBLE CONTRACEPTIVES: A STATE-LEVEL BUDGET IMPACT MODEL OF SOUTH CAROLINA
Mar 18, 2026, 21:38 PM -
VALIDATION OF A NEW CLINICAL OUTCOME ASSESSMENT: THE VACCINATION EXPERIENCE QUESTIONNAIRE (VEQ)
Mar 18, 2026, 21:38 PM -
REAL-WORLD SAFETY TRENDS OF GLP-1 RECEPTOR AGONISTS IN THE UNITED STATES: ANALYSIS OF FAERS REPORTS (2015-2025)
Mar 18, 2026, 21:38 PM -
HEALTH OUTCOMES AND IMPLEMENTATION EFFECTIVENESS OF THE ANKYLOSING SPONDYLITIS RURAL HEALTH PROJECT IN CHINA: A PROSPECTIVE COHORT STUDY FROM HEALTH EQUITY PERSPECTIVE
Mar 18, 2026, 21:38 PM -
COMPARATIVE MEASUREMENT OF ESKETAMINE RESPONSE IN TREATMENT-RESISTANT DEPRESSION USING PHQ-9 AND DSM-5 CRITERIA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LATENT TUBERCULOSIS INFECTION INTERVENTIONS IMPLEMENTED DURING THE TUBERCULOSIS EPIDEMIOLOGIC STUDIES CONSORTIUM (TBESC-III)
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH TREATMENT ENGAGEMENT AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER AFTER DISCHARGE: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERN IN PATIENTS WITH ADVANCED BREAST CANCER AFTER CDK4/6I FAILURE IN CHINA
Mar 18, 2026, 21:38 PM
